Roger Crystal, Chief Executive Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 57,546 shares at $11.98 ($692K) on 2019-04-05, disclosed to the SEC on 2019-04-08.
Open-market sale of $692k OPNT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.98 | 16,001 | $192K | 27.7% |
| 2 | $11.98 | 16,001 | $192K | 27.7% |
| 3 | $12.10 | 12,772 | $155K | 22.3% |
| 4 | $12.10 | 12,772 | $155K | 22.3% |
| Total | $12.03 avg | 57,546 | $692K | 100% |
| Filing → |
| OPNT | SELL | 2023-01-05 | $203K | — | Filing → |
| OPNT | SELL | 2022-07-15 | $25K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $104K | — | Filing → |